Lonza shares rose on market rumours that EMS Chemie is considering acquiring the company.
Reuters
Saturday 20 February 2010
EMS Chemie interested in Lonza?
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2010
(311)
-
▼
February
(35)
- Pharma sales decline at DSM
- Aesica plans expansion
- Cabb has received ISO 14001 certification for its ...
- Recipharm launches new biologics unit
- EMS Chemie interested in Lonza?
- AMRI acquires Excelsyn
- Pharmatek Laboratories has received Drug Enforceme...
- Inabata & Co will market Ampac Fine Chemicals' API...
- Codexis selects Dishman and Ampac Fine Chemicals
- Aptuit has introduced a production screen to bette...
- Dottikon will introduce short working to address c...
- Albemarle to provide manufacturing for PharmaCore ...
- Piramal Healthcare is considering expanding its bi...
- Novasep and Provepharm have successfully validated...
- Aurelius acquires Isochem
- Synthetech sales declined 52% in its Q3 2009 vs 2008
- Revenues for AmPac Fine Chemicals fell 53% in the ...
- Cambrex sales decline in Q4
- Year ends with an upturn for SAFC
- BASF will perform cGMP spray drying tests and pilo...
- Ricerca Biosciences will acquire the MDS Pharma Se...
- EFCG welcomes excipient amendments
- International Stem Cell Corporation has opened its...
- Angel Biotechnology will provide consultancy and d...
- Socma has welcomed US Senate moves to reauthorise ...
- Dishman's Naroda, Ahmedabad, API manufacturing fac...
- Dishman restructures Carbogen Amcis
- Recipharm has declared its offer for Cobra Biomanu...
- Angel Biotechnology has raised £1.4m through a pla...
- SynCo signs US deal
- UKTI and Chemspec USA
- Peakdale Molecular will establish a synthetic chem...
- Watson acquires Eden
- Tough year for Lonza in 2009; cautiously optimisti...
- Carbogen Amcis has inaugurated its high containmen...
-
▼
February
(35)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment